The Evolving Role of Enzalutamide on the Treatment of Prostate Cancer

Future Oncology - United Kingdom
doi 10.2217/fon.15.351
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

Initial Experience of the Enzalutamide Treatment for Castration-Resistant Prostate Cancer

Japanese Journal of Urology
Urology
2016English

The Evolving Role of Multiparametric Mri in Prostate Cancer Work-Up.

International Journal of Advanced Research
2018English

Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

Klinicka Onkologie
Oncology
2016English

The Evolving Role of Tissue Biospecimens in the Treatment of Cancer

2011English

Evolving Role of Cetuximab in the Treatment of Colorectal Cancer

Cancer Management and Research
Oncology
2009English

Evolving Role of Cetuximab in the Treatment of Colorectal Cancer

Cancer Management and Research
Oncology
2009English

Eyeing Enzalutamide for Hormone-Sensitive Prostate Cancer

Cancer Discovery
Oncology
2019English

Metastatic Castration-Resistant Prostate Cancer: Critical Review of Enzalutamide

Clinical Medicine Insights: Oncology
Oncology
2013English

Evidence for the Efficacy of Enzalutamide in Postchemotherapy Metastatic Castrate-Resistant Prostate Cancer

Therapeutic Advances in Urology
Urology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy